Skip to main content

Published locations for KEYNOTE-177 delivers final results with pembrolizumab vs chemotherapy for MSI-H or dMMR mCRC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. KEYNOTE-177 delivers final results with pembrolizumab vs chemotherapy for MSI-H or dMMR mCRC

User login

  • Reset your password
  • /content/keynote-177-delivers-final-results-pembrolizumab-vs-chemotherapy-msi-h-or-dmmr-mcrc
  • /hematology-oncology/article/255011/gastrointestinal-cancer/keynote-177-delivers-final-results